Huge news! These are for patients with incurable cancers and the CYCC drug combo worked for many of these patients.
"We have seen several responses among these patients, as well as instances of prolonged stable disease lasting more than a year," said Geoffrey Shapiro, MD, PhD, director of Dana-Farber's Early Drug Development Center (EDDC).
It does. You can see only 16 out of the total had BRCA mutations with responses. BRCA deficient is bad news. 1 year response is great. Just look up initial prognosis for these types of CA and you'll understand.